Pfizer
Dan Carney has extensive experience in procurement and sourcing within the healthcare sector, currently serving as a Senior Director at Pfizer since November 2007. Throughout tenure at Pfizer, Dan Carney has held various leadership roles, including Senior Director of S2P Operations Lead, Strategic Sourcing for HR and Professional Services, and Global Procurement for HR and Contingent Labor. Prior to Pfizer, Dan Carney worked at Boston Scientific as a Senior Manager in Global Sourcing and held sourcing management positions at Hill-Rom and Electronic Data Systems. Dan Carney obtained an MBA in Finance, Operations, and Strategy from Purdue University Daniels School of Business and a Bachelor of Science in Mechanical Engineering from Rose-Hulman Institute of Technology.
This person is not in any teams
Pfizer
606 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.